Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Multi-center, Open Label First-in-Human Study With ABBV-CLS-579 Alone and in Combination in Subjects With Locally Advanced or Metastatic Tumors

NCT04417465 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04417465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04417465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Multi-center, Open Label First-in-Human Study With ABBV-CLS-579 Alone and in Combination in Subjects With Locally Advanced or Metastatic Tumors
Lead sponsor
AbbVie
Phase
Phase 1
Overall status
Completed
Start date
June 3, 2020
Completion date
August 21, 2025
Enrollment
101 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors cancer